IFNG and neoplasm: In preclinical models, treatment with IMM-101 appeared to increase the secretion of IFNγ and cytotoxic mediators such as perforin and granzyme B at the tumor site, the draining lymph nodes and in the spleen in tumor-bearing mice.56